Recent FDA Approval Opens New Possibilities for CAR T-cell Therapies
Jul 31, 2018
CHOP has been at the forefront of developing cell therapy to treat ALL. Some next steps include initiating clinical trials for AML and, ultimately, making this treatment work for solid tumors.